SCHEMBL9564362

SCHEMBL9564362

CCN/C(=C\C(=O)c1cc(Cl)sc1Cl)SC

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.42
DAO P14920 1/20 0.41
RAB9A P51151 4/20 0.40
MAPT P10636 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 2/20 0.40
HPGD P15428 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.36
KDR P35968 3/20 0.36
LMNA P02545 3/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9564345 0.77 KDR (0.34) RAB9AMAPTNPC1KMT2AKDR
SCHEMBL9564349 0.77 KDR (0.34) RAB9AMAPTNPC1KMT2AKDR
SCHEMBL9564386 0.76 DAO (0.41) DAORAB9AMAPTSMN1; SMN2HPGD
SCHEMBL10874394 0.71 MAPT (0.48) RAB9AMAPTSMN1; SMN2NPC1HPGD
SCHEMBL9564372 0.69 KMT2A (0.43) DAORAB9AMAPTSMN1; SMN2NPC1
SCHEMBL9564365 0.69 KMT2A (0.43) DAORAB9AMAPTSMN1; SMN2NPC1
SCHEMBL9564382 0.69 KMT2A (0.44) GSK3BDAORAB9AMAPTSMN1; SMN2
SCHEMBL9564369 0.69 ALDH1A1 (0.49) GSK3BMAPTSMN1; SMN2MAPK1KMT2A
SCHEMBL9564408 0.68 ALDH1A1 (0.39) RAB9ASMN1; SMN2NPC1L3MBTL1KDM4E
SCHEMBL9591168 0.67 DAO (0.61) GSK3BDAORAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0563686-A1 Utilization of 3 substituted amino isoxazole derivatives against endoparasites, new 3 substituted amino isoxazols and process for their preparation BAYER AG (DE) 1993-10-06 EP disclosed